SCHEMBL4856239

SCHEMBL4856239

[CH2]CC(=O)OCC(OC)OCC

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4848161 0.90 MGAM (0.34) MGAMGAASIMGAM2
SCHEMBL4854694 0.86 MAPT (0.34)
SCHEMBL8641999 0.81 MAPT (0.47)
SCHEMBL9748310 0.80 ALDH1A1 (0.44) MGAMGAASIMGAM2
SCHEMBL8918549 0.80 MAPT (0.35)
SCHEMBL8894699 0.80 ALDH1A1 (0.36)
SCHEMBL26300306 0.79 ALDH1A1 (0.46) MGAMGAASIMGAM2
SCHEMBL11544393 0.77 ALDH1A1 (0.31)
SCHEMBL1397463 0.76 TSHR (0.53) MGAMGAASIMGAM2
SCHEMBL2332613 0.76 TSHR (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329694-B2 Ocular lens JOHNSON & JOHNSON VISION CARE, INC. (US) 2008-02-12 US disclosed
EP-1445641-B1 OCULAR LENS JOHNSON & JOHNSON VISION CARE (US) 2007-10-03 EP disclosed
US-20040201820-A1 Ocular lens JOHNSON & JOHNSON VISION CARE, INC. 2004-10-14 US disclosed
US-20040198938-A1 Monomers, polymers and ophthalmic lenses JOHNSON & JOHNSON VISION CARE, INC. 2004-10-07 US disclosed
EP-1445641-A1 OCULAR LENS Johnson & Johnson Vision Care, Inc. (US) 2004-08-11 EP disclosed
EP-1424339-A1 MONOMERS, POLYMERS AND OPHTHALMIC LENSES Johson & Johnson Vision Care Inc. (US) 2004-06-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198938-A1 Monomers, polymers and ophthalmic lenses LOXL1, CRYAA, UACA MGAM 1176/4885GAA 3218/4885SI 4436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.